225 related articles for article (PubMed ID: 31063831)
1. Insights into mechanisms and severity of drug-induced liver injury via computational systems toxicology approach.
Peng Y; Wu Z; Yang H; Cai Y; Liu G; Li W; Tang Y
Toxicol Lett; 2019 Sep; 312():22-33. PubMed ID: 31063831
[TBL] [Abstract][Full Text] [Related]
2. In-silico approach for drug induced liver injury prediction: Recent advances.
Saini N; Bakshi S; Sharma S
Toxicol Lett; 2018 Oct; 295():288-295. PubMed ID: 29981923
[TBL] [Abstract][Full Text] [Related]
3. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
[TBL] [Abstract][Full Text] [Related]
4. Insights into the molecular mechanisms of Polygonum multiflorum Thunb-induced liver injury: a computational systems toxicology approach.
Wang YY; Li J; Wu ZR; Zhang B; Yang HB; Wang Q; Cai YC; Liu GX; Li WH; Tang Y
Acta Pharmacol Sin; 2017 May; 38(5):719-732. PubMed ID: 28239160
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.
Dragovic S; Vermeulen NP; Gerets HH; Hewitt PG; Ingelman-Sundberg M; Park BK; Juhila S; Snoeys J; Weaver RJ
Arch Toxicol; 2016 Dec; 90(12):2979-3003. PubMed ID: 27659300
[TBL] [Abstract][Full Text] [Related]
6. Advancing Predictive Hepatotoxicity at the Intersection of Experimental, in Silico, and Artificial Intelligence Technologies.
Fraser K; Bruckner DM; Dordick JS
Chem Res Toxicol; 2018 Jun; 31(6):412-430. PubMed ID: 29722533
[TBL] [Abstract][Full Text] [Related]
7. Current limitations and future opportunities for prediction of DILI from in vitro.
Funk C; Roth A
Arch Toxicol; 2017 Jan; 91(1):131-142. PubMed ID: 27766365
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced liver injury: what was new in 2008?
Liss G; Lewis JH
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):843-60. PubMed ID: 19505188
[TBL] [Abstract][Full Text] [Related]
9. Prediction of drug-induced liver injury using keratinocytes.
Hirashima R; Itoh T; Tukey RH; Fujiwara R
J Appl Toxicol; 2017 Jul; 37(7):863-872. PubMed ID: 28138970
[TBL] [Abstract][Full Text] [Related]
10. Development of a cell-based assay system considering drug metabolism and immune- and inflammatory-related factors for the risk assessment of drug-induced liver injury.
Yano A; Oda S; Fukami T; Nakajima M; Yokoi T
Toxicol Lett; 2014 Jul; 228(1):13-24. PubMed ID: 24747151
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced liver injury.
Holt M; Ju C
Handb Exp Pharmacol; 2010; (196):3-27. PubMed ID: 20020257
[TBL] [Abstract][Full Text] [Related]
12. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.
Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W
Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315
[TBL] [Abstract][Full Text] [Related]
13. Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity.
Herpers B; Wink S; Fredriksson L; Di Z; Hendriks G; Vrieling H; de Bont H; van de Water B
Arch Toxicol; 2016 May; 90(5):1163-79. PubMed ID: 26026609
[TBL] [Abstract][Full Text] [Related]
14. Toward predictive models for drug-induced liver injury in humans: are we there yet?
Chen M; Bisgin H; Tong L; Hong H; Fang H; Borlak J; Tong W
Biomark Med; 2014; 8(2):201-13. PubMed ID: 24521015
[TBL] [Abstract][Full Text] [Related]
15. In Silico Identification of Proteins Associated with Drug-induced Liver Injury Based on the Prediction of Drug-target Interactions.
Ivanov S; Semin M; Lagunin A; Filimonov D; Poroikov V
Mol Inform; 2017 Jul; 36(7):. PubMed ID: 28145637
[TBL] [Abstract][Full Text] [Related]
16. Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
Eun JW; Bae HJ; Shen Q; Park SJ; Kim HS; Shin WC; Yang HD; Jin CY; You JS; Kang HJ; Kim H; Ahn YM; Park WS; Lee JY; Nam SW
J Appl Toxicol; 2015 Feb; 35(2):152-64. PubMed ID: 25231249
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.
Yucha RW; He K; Shi Q; Cai L; Nakashita Y; Xia CQ; Liao M
Toxicol Sci; 2017 Jun; 157(2):487-499. PubMed ID: 28369588
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced liver injury: a safety review.
García-Cortés M; Ortega-Alonso A; Lucena MI; Andrade RJ;
Expert Opin Drug Saf; 2018 Aug; 17(8):795-804. PubMed ID: 30059261
[TBL] [Abstract][Full Text] [Related]
19. Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs.
Gómez-Lechón MJ; Tolosa L; Donato MT
J Appl Toxicol; 2016 Jun; 36(6):752-68. PubMed ID: 26691983
[TBL] [Abstract][Full Text] [Related]
20. Prediction models for drug-induced hepatotoxicity by using weighted molecular fingerprints.
Kim E; Nam H
BMC Bioinformatics; 2017 May; 18(Suppl 7):227. PubMed ID: 28617228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
